Aiolos Bio’s Post

View organization page for Aiolos Bio, graphic

3,750 followers

Today we are proud to announce a definitive merger agreement under which GSK will acquire Aiolos Bio for a total value of $1.4B. This deal will enable us to advance our mission of helping patients breathe easier and reducing their treatment burden by capitalizing on GSK’s global scale and considerable experience in developing and commercializing respiratory therapies. We are incredibly proud of what we have accomplished and can’t think of a better partner to help take AIO-001 into its next stage of development. To learn more please click here: https://lnkd.in/ghwpPhGv

Congratulations! #MergerLinks #HealthCare

Good work all around. Congratulations!!

Like
Reply
Tony Gibney

Biotech Investment Banker for 25 Years, Biotech CBO/CFO for 6 years, Board Member

9mo

Thrilled for you, Maha

Like
Reply
Lauren Hauser

Accomplished Clinical Project Manager || Over 10 years of clinical research experience | Clinical Operations | Phase 1-3 | Gene Therapy | Rare Disease | Ophthalmology | Respiratory

9mo

Congratulations, Aiolos team!

Like
Reply
Ilenia Nardolillo

Master Degree in Biology for Scientific Research 💊🧪 | Strategic Business Developer | 🔬 Expert in Lab Equipment & Research Tools | Marketing & Communication Specialist 🚀

9mo

Great work! Congratulations!

Jann Key - Ague

Vice President of Business Development West Coast Biotech at Syneos Health

9mo

Congratulations!

Like
Reply
Kristen Schmit

Quality and Clinical professional. Traveling sailor, scuba diver, skier and motorcycle rider.

9mo

Congratulations!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics